Kelly R. Reveles

Kelly R. Reveles is an Associate Professor at The University of Texas at Austin College of Pharmacy and an Adjunct Associate Professor at UT Health San Antonio School of Medicine. She earned her Pharm.D. (2010) and dual-Ph.D. in Translational Science (2014) from UT Austin and UT Health Science Center San Antonio. Her research focuses on reducing healthcare-associated infections, particularly Clostridioides difficile, through translational strategies spanning microbiome analysis, clinical trials, and pharmacoepidemiology. She leads NIH-funded studies including a $3.4M R01 grant investigating fecal microbiota transplantation’s impact on aging in marmosets.

• Education:
  • Pharm.D., UT Austin College of Pharmacy & UT Health Science Center San Antonio (2010)
  • Ph.D., Translational Science (UT Austin, UT Health San Antonio, and UT San Antonio) (2014)
• Key Roles:
  • Graduate Advisor at UT Austin College of Pharmacy
  • Co-leader, Pilot & Exploratory Studies Core at San Antonio Pepper Older Americans Independence Center

Her research emphasizes multidisciplinary approaches to combat antimicrobial resistance, improve microbiome-targeted therapies, and address healthcare disparities. Major grants include NIH/NIA funding for microbiome-aging studies and AstraZeneca collaborations on cancer outcomes. Media highlights include New York Times coverage of her C. difficile work.

Awards:

• Young Investigator Award (Society of Infectious Diseases Pharmacists, 2020)
• Ambulatory Care Paper of the Year (2021, 2019)
• Outstanding Faculty Advisor (2021)

Grant Leadership:

• Principal Investigator: NIH/NIA Grant (2021-2024) studying microbiota-associated mice for aging research
• Co-PI: $3.4M NIH/NIA Grant (2020-2025) on microbiome-mediated therapies in marmosets
• Co-Investigator: Texas Targeted Opioid Response (2019-2024)

Her work bridges clinical practice and public health, addressing urgent issues like hospital-acquired infections, opioid misuse, and antibiotic stewardship. She actively collaborates with academic, clinical, and industry partners to translate research into actionable healthcare solutions.